{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:03:11Z","timestamp":1774915391867,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.carrev.2025.03.018","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:48:10Z","timestamp":1742672890000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Angina in stable coronary artery disease: Data from ORBITA and ORBITA-2"],"prefix":"10.1016","volume":"76","author":[{"given":"Shayna","family":"Chotai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Salih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiyyaz","family":"Ahmed-Jushuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha K.","family":"Al-Lamee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"49","key":"10.1016\/j.carrev.2025.03.018_bb0005","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1055\/s-0028-1108161","volume":"99","author":"Gr\u00fcntzig","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"issue":"15","key":"10.1016\/j.carrev.2025.03.018_bb0010","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2025.03.018_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199201023260102","article-title":"A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators","volume":"326","author":"Parisi","year":"1992","journal-title":"N Engl J Med"},{"issue":"9076","key":"10.1016\/j.carrev.2025.03.018_bb0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants","volume":"350","year":"1997","journal-title":"Lancet"},{"issue":"7253","key":"10.1016\/j.carrev.2025.03.018_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.321.7253.73","article-title":"Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials","volume":"321","author":"Bucher","year":"2000","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.carrev.2025.03.018_bb0030","doi-asserted-by":"crossref","first-page":"e1373","DOI":"10.4244\/EIJV13I12A217","article-title":"Swimming against the tide: insights from the ORBITA trial","volume":"13","author":"Al-Lamee","year":"2017","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1016\/j.carrev.2025.03.018_bb0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2025.03.018_bb0040","doi-asserted-by":"crossref","unstructured":"Rajkumar CA, Nijjer SS, Cole GD, Al-Lamee R, Francis DP. \u2018Faith healing\u2019 and \u2018subtraction anxiety\u2019 in unblinded trials of procedures: lessons from DEFER and FAME-2 for end points in the ISCHEMIA trial. Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004665. doi:https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.004665. Erratum in: Circ Cardiovasc Qual Outcomes 2018 Apr;11(4):e000038. doi:https:\/\/doi.org\/10.1161\/HCQ.0000000000000038. Title corrected. PMID: 29530888.","DOI":"10.1161\/CIRCOUTCOMES.118.004665"},{"key":"10.1016\/j.carrev.2025.03.018_bb0045","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","article-title":"Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis\u202f: a randomized trial","volume":"103","author":"Bech","year":"2001","journal-title":"Circulation"},{"issue":"10115","key":"10.1016\/j.carrev.2025.03.018_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.carrev.2025.03.018_bb0055","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial","volume":"107","author":"Borer","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.carrev.2025.03.018_bb0060","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.carrev.2025.03.018_bb0065","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/CIRCULATIONAHA.118.033801","article-title":"Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel coronary artery disease","volume":"138","author":"Al-Lamee","year":"2018","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.carrev.2025.03.018_bb0070","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCULATIONAHA.119.042918","article-title":"Dobutamine stress echocardiography ischemia as a predictor of the placebo-controlled efficacy of Percutaneous coronary intervention in stable coronary artery disease: the stress echocardiography-stratified analysis of ORBITA","volume":"140","author":"Al-Lamee","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.03.018_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ahj.2019.06.014","article-title":"Current landscape of hybrid revascularization: a report from the NCDR CathPCI Registry","volume":"215","author":"Lowenstern","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2025.03.018_bb0080","doi-asserted-by":"crossref","unstructured":"Christiaan Vrints, Felicita Andreotti, Konstantinos C Koskinas, Xavier Rossello, Marianna Adamo, James Ainslie, Adrian Paul Banning, Andrzej Budaj, Ronny R Buechel, Giovanni Alfonso Chiariello, Alaide Chieffo, Ruxandra Maria Christodorescu, Christi Deaton, Torsten Doenst, Hywel W Jones, Vijay Kunadian, Julinda Mehilli, Milan Milojevic, Jan J Piek, Francesca Pugliese, Andrea Rubboli, Anne Grete Semb, Roxy Senior, Jurrien M ten Berg, Eric Van Belle, Emeline M Van Craenenbroeck, Rafael Vidal-Perez, Simon Winther, ESC Scientific Document Group, 2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, Volume 45, Issue 36, 21 September 2024, Pages 3415\u20133537, doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehae177.","DOI":"10.1093\/eurheartj\/ehae177"},{"issue":"9","key":"10.1016\/j.carrev.2025.03.018_bb0085","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.carrev.2025.03.018_bb0090","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","article-title":"ORBITA-2 Investigators. A placebo-controlled trial of Percutaneous coronary intervention for stable angina","volume":"389","author":"Rajkumar","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.carrev.2025.03.018_bb0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ehjdh\/ztac015","article-title":"Daily angina documentation versus subsequent recall: development of a symptom smartphone app","volume":"3","author":"Nowbar","year":"2022","journal-title":"Eur Heart J Digit Health"},{"key":"10.1016\/j.carrev.2025.03.018_bb0100","doi-asserted-by":"crossref","unstructured":"Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, Chotai S, Seligman H, Macierzanka K, Davies JR, Keeble TR, O'Kane P, Haworth P, Routledge H, Kotecha T, Clesham G, Williams R, Din J, Nijjer SS, Curzen N, Sinha M, Petraco R, Spratt J, Sen S, Cole GD, Harrell FE Jr, Howard JP, Francis DP, Shun-Shin MJ, Al-Lamee R; ORBITA-2 Investigators. Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable coronary artery disease. Circulation. 2025 Jan 21;151(3):202\u2013214. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.072281. Epub 2024 Oct 27. PMID: 39462291; PMCID: PMC11748910.","DOI":"10.1161\/CIRCULATIONAHA.124.072281"},{"key":"10.1016\/j.carrev.2025.03.018_bb0105","unstructured":"Ahmed-Jushuf F, Foley MJ, Rajkumar CA, Chotai S, Simader FA et al. Ischemia on dobutamine stress echocardiography predicts efficacy of PCI: results from ORBITA-2. Accepted to J Am Coll Cardiol on 27\/02\/2025; awaiting publication."},{"key":"10.1016\/j.carrev.2025.03.018_bb0110","doi-asserted-by":"crossref","unstructured":"Simader FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Chotai S, Bual N, Khokhar A, Gohar A, Lampadakis I, Ganesananthan S, Pathimagaraj RH, Nowbar A, Davies JR, Keeble TR, O'Kane PD, Haworth P, Routledge H, Kotecha T, Spratt JC, Williams R, Nijjer SS, Sen S, Curzen N, Sinha M, Howard JP, Cole G, Harrell FE Jr, Francis DP, Shun-Shin MJ, Al-Lamee RK; ORBITA-2 Investigators. Symptoms as a predictor of the placebo-controlled efficacy of PCI in stable coronary artery disease. J Am Coll Cardiol. 2024 Jul 2;84(1):13\u201324. doi:https:\/\/doi.org\/10.1016\/j.jacc.2024.04.016. Epub 2024 May 15. PMID: 38759906.","DOI":"10.1016\/j.jacc.2024.04.016"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:29:48Z","timestamp":1752607788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":22,"alternative-id":["S1553838925001198"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.03.018","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angina in stable coronary artery disease: Data from ORBITA and ORBITA-2","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}